Ratings by Jefferies (Eun Yang)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/25/2024 | Aerovate Therapeutics Inc | AVTE | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2024 | Rallybio Corp. | RLYB | Downgrade | Hold (Buy) |
1.25 (1.77) |
41.6% | Details | |
| 12/15/2023 | Reneo Pharmaceuticals | RPHM | Downgrade | Hold (Buy) |
7.75 (1.69) |
-78.19% | Details | |
| 8/15/2023 | Aerovate Therapeutics Inc | AVTE | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | BridgeBio Pharma | BBIO | Downgrade | Hold (Buy) |
18.22 (25.07) |
37.6% | Details | |
| 7/12/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2023 | Biomea Fusion Inc. | BMEA | Downgrade | Hold (Buy) |
30.67 (10.83) |
-64.69% | Details | |
| 5/4/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Enliven Therapeutics | ELVN | New Coverage | Buy (N/A) |
23.10 (17.62) |
-23.72% | Details | |
| 2/23/2023 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2023 | Taysha Gene Therapies | TSHA | Downgrade | Hold (Buy) |
1.54 (2.46) |
59.74% | Details | |
| 1/24/2023 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2023 | Albireo Pharma | ALBO | Downgrade | Hold (Buy) |
43.85 (44.15) |
0.68% | Details | |
| 1/9/2023 | CureVac | CVAC | Maintain | Buy (Hold) |
|
Details | ||
| 12/16/2022 | Astria Therapeutics | ATXS | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Lumos Pharma | LUMO | Downgrade | Hold (Buy) |
4.83 (2.68) |
-44.51% | Details | |
| 11/14/2022 | Lumos Pharma | LUMO | Downgrade | Hold (Buy) |
8.91 (2.68) |
-69.92% | Details | |
| 11/14/2022 | Prime Medicine | PRME | New Coverage | Buy (N/A) |
20.57 (4.78) |
-76.76% | Details | |
| 11/9/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Rallybio Corp. | RLYB | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2022 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2022 | Rigel Pharmaceuticals | RIGL | Downgrade | Hold (Buy) |
1.76 (1.13) |
-35.8% | Details | |
| 5/24/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2022 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2021 | Pyxis Oncology Inc. | PYXS | New Coverage | Buy (N/A) |
13.34 (4.53) |
-66.04% | Details | |
| 10/20/2021 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 10/4/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2021 | Astria Therapeutics | ATXS | New Coverage | Buy (N/A) |
9.53 (9.80) |
2.83% | Details | |
| 8/23/2021 | Rallybio Corp. | RLYB | New Coverage | Buy (N/A) |
12.92 (1.77) |
-86.3% | Details | |
| 8/3/2021 | Translate Bio | TBIO | Downgrade | Hold (Buy) |
29.15 (0.32) |
-98.9% | Details | |
| 7/26/2021 | Aerovate Therapeutics Inc | AVTE | New Coverage | Buy (N/A) |
14.23 (22.17) |
55.8% | Details | |
| 7/15/2021 | Generation Bio | GBIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2021 | Verve Therapeutics | VERV | New Coverage | Buy (N/A) |
46.25 (6.91) |
-85.06% | Details | |
| 7/8/2021 | Nabriva Therapeutics AG | NBRV | New Coverage | Hold (N/A) |
1.27 (1.42) |
11.81% | Details | |
| 6/22/2021 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
24.91 (10.00) |
-59.86% | Details | |
| 6/9/2021 | Cogent | COGT | New Coverage | Buy (N/A) |
7.85 (7.12) |
-9.3% | Details | |
| 5/11/2021 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
20.52 (2.46) |
-88.01% | Details | |
| 5/11/2021 | Biomea Fusion Inc. | BMEA | New Coverage | Buy (N/A) |
16.94 (10.83) |
-36.07% | Details | |
| 5/4/2021 | Reneo Pharmaceuticals | RPHM | New Coverage | Buy (N/A) |
14.40 (1.69) |
-88.26% | Details | |
| 4/8/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2021 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2021 | Five Prime Therapeutics | FPRX | Downgrade | Hold (Buy) |
21.26 (38.00) |
78.74% | Details | |
| 3/2/2021 | Paratek Pharmaceuticals | PRTK | New Coverage | Buy (N/A) |
7.48 (2.23) |
-70.19% | Details | |
| 1/27/2021 | BridgeBio Pharma | BBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2020 | Dyne Therapeutics | DYN | New Coverage | Buy (N/A) |
18.99 (24.87) |
30.96% | Details | |
| 9/8/2020 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | CureVac | CVAC | New Coverage | Hold (N/A) |
56.92 (2.53) |
-95.56% | Details | |
| 8/14/2020 | Lumos Pharma | LUMO | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Radius Health | RDUS | Maintain | Hold (N/A) |
|
Details | ||
| 8/11/2020 | Halozyme Therapeutics | HALO | Maintain | Underperform (N/A) |
|
Details | ||
| 8/7/2020 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2020 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
19.56 (2.81) |
-85.63% | Details | |
| 5/18/2020 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2020 | Halozyme Therapeutics | HALO | Maintain | Underperform (N/A) |
|
Details | ||
| 4/16/2020 | Lumos Pharma | LUMO | New Coverage | Buy (N/A) |
9.21 (2.68) |
-70.9% | Details | |
| 3/10/2020 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
98.26 (234.06) |
138.2% | Details | |
| 3/10/2020 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Hold) |
98.26 (234.06) |
138.2% | Details | |
| 10/16/2019 | Alexion Pharmaceuticals | ALXN | Maintain | Hold (N/A) |
|
Details | ||
| 9/30/2019 | Deciphera | DCPH | New Coverage | Buy (N/A) |
32.86 (14.58) |
-55.63% | Details | |
| 8/1/2019 | United Therapeutics Corp. | UTHR | Upgrade | Hold (Underperform) |
79.53 (234.06) |
194.3% | Details | |
| 7/23/2019 | Ionis Pharmaceuticals | IONS | Maintain | Underperform (N/A) |
|
Details | ||
| 7/22/2019 | Translate Bio | TBIO | New Coverage | Buy (N/A) |
9.60 (29.15) |
203.65% | Details | |
| 7/22/2019 | BridgeBio Pharma | BBIO | New Coverage | Buy (N/A) |
26.00 (25.07) |
-3.58% | Details | |
| 6/18/2019 | Ra Pharma | RARX | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | Array BioPharma | ARRY | Downgrade | Hold (Buy) |
29.59 (11.69) |
-60.49% | Details | |
| 5/28/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2019 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2019 | La Jolla Pharma | LJPC | Upgrade | Hold (Underperform) |
6.10 (6.22) |
1.97% | Details | |
| 12/20/2018 | DBV Technologies S.A | DBVT | Downgrade | Hold (Buy) |
14.69 (0.66) |
-95.51% | Details | |
| 10/30/2018 | Array BioPharma | ARRY | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2018 | AMAG Pharmaceuticals | AMAG | Maintain | Hold (N/A) |
|
Details |
